"Momentum Continues": Lilly Jumps After Raising Revenue Outlook On Surging GLP-1 Demand
--------------------------------------------------------------------
Source: Zero Hedge
Published: 2026-08-05 21:45 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Business, Health, Drugs
--------------------------------------------------------------------
Snippet:
Shares of Eli Lilly & Co. are rising in premarket trading after the pharmaceutical giant raised its full-year revenue forecast following a 48% jump in second-quarter sales, fueled by accelerating demand for the diabetes drug Mounjaro and the obesity treatment Zepbound.
--------------------------------------------------------------------